Medtronic Guardian Connect
Medtronic Guardian™ Connect CGM
Medtronic Guardian™ Connect CGM is the world’s first Smart Continuous Glucose Monitoring (CGM)* system for people with diabetes. With breakthrough tools to outsmart the highs and lows of diabetes, the Guardian Connect CGM allows you to focus on your life — not on your levels. Using smart technology to predict where your glucose levels are headed, the system will alert you from 10 to 60 minutes before a high or low.
Customizable glucose alerts built for you
Real-time glucose trends through the app
Updates glucose data every 5 minutes
Can be used for those living with Type 1 or Type 2 diabetes
The Guardian™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes.
Once you have enrolled, your dedicated Diabetes Care Advisor (DCA) will verify your insurance benefits and obtain a prescription from your physician. Within two business days, your DCA will contact you to explain your options and go over what you need. We handle the necessary paperwork between your insurance and your healthcare team, keeping you updated every step of the way.
MiniMed™ insulin pumps use a different transmitter to communicate to the pump, versus Guardian™ Connect, which communicates to the smartphone.
InPen
Take the right insulin dose at the right time.
Introducing the InPen — a more intelligent insulin pen. Experience the ease of a traditional insulin pen coupled with the valuable data and decision support found in advanced insulin delivery systems. Transform your approach to managing multiple daily insulin injections (MDI) as InPen seamlessly monitors your insulin data and offers personalized recommendations.
*The Guardian™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus.
*The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained using a home blood glucose meter and not on values provided by the system. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and important safety information.
*Alerts must be set to receive predictive alerts.
Important Safety Information: Guardian™ Connect CGM System
The Guardian™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and http://www.medtronicdiabetes.com/importantsafetyinformation.